No Shareholder Action Required at This Time ...
The Company's shareholders do not need to take any action at this time.
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that it has entered into binding terms to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results